Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Acta Pharmaceutica Sinica ; (12): 346-349, 2003.
Article in Chinese | WPRIM | ID: wpr-251088

ABSTRACT

<p><b>AIM</b>To study asymmetric total synthesis of 14-nor-huperzine A 2 and its inhibitory activity on acetylcholinesterase.</p><p><b>METHODS</b>Highly enantioselective synthesis of compound 5 from beta-keto-ester 3 and 2-methylene-1,3-propanediol diacetate 4 by palladium-catalyzed bicycloannulation was carried out using new chiral ferrocenylphosphine ligands, such as 10, 11, followed by regioselective double-bond migration to produce compound 6. Optically pure 6 was obtained after enantio-enrichment recrystallization. Then, according to similar procedures of huperzine A synthesis, the target compound 14-nor-huperzine A 2 was prepared. The inhibitory activity was tested with rat erythrocyte membrame acetylcholinesterase.</p><p><b>RESULTS</b>The inhibitory activity of synthetic (-)-14-nor-huperzine A was 8 fold less potent than that of (-)-huperzine A.</p><p><b>CONCLUSION</b>A hydrogen-bond between 14-methyl group of (-) huperzine A and the main-chain oxygen of His 440 is necessary for the highly acetylcholinesterase inhibitory activity of huperzine A.</p>


Subject(s)
Animals , Rats , Acetylcholinesterase , Metabolism , Alkaloids , Alzheimer Disease , Drug Therapy , Cholinesterase Inhibitors , Pharmacology , Therapeutic Uses , Erythrocyte Membrane , Molecular Conformation , Molecular Structure , Sesquiterpenes , Chemistry , Pharmacology , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL